COVID-19 Impact on Hormonal Contraceptive Market, Global Research Reports 2020-2021

COVID-19 Impact on Hormonal Contraceptive Market, Global Research Reports 2020-2021

May 2020 QYResearch Healthcare99 Pages Price :
$ 3250
This report covers market size and forecasts of Hormonal Contraceptive, including the following market information:
Global Hormonal Contraceptive Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Hormonal Contraceptive Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Hormonal Contraceptive Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Hormonal Contraceptive Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Ansell Limited, Bayer AG, Church and Dwight Co, Johnson and Johnson, Mayer Laboratories, Merck and Co, Mylan N.V., Pfizer, Teva Pharmaceutical Industries, The Female Health Company, Organon International, Afaxys, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Oral Contraceptive Pills
Injectable Birth Control
Emergency Contraceptive Pills
Vaginal Rings
Transdermal Patches

Based on the Application:
Hospitals
Household
Clinics
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Hormonal Contraceptive Industry
1.7 COVID-19 Impact: Hormonal Contraceptive Market Trends

2 Global Hormonal Contraceptive Quarterly Market Size Analysis
2.1 Hormonal Contraceptive Business Impact Assessment - COVID-19
2.1.1 Global Hormonal Contraceptive Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Hormonal Contraceptive Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Hormonal Contraceptive Quarterly Market Size, 2019 VS 2020
3.2 By Players, Hormonal Contraceptive Headquarters and Area Served
3.3 Date of Key Players Enter into Hormonal Contraceptive Market
3.4 Key Players Hormonal Contraceptive Product Offered
3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Hormonal Contraceptive Segments, By Type
4.1 Introduction
1.4.1 Oral Contraceptive Pills
1.4.2 Injectable Birth Control
1.4.3 Emergency Contraceptive Pills
1.4.4 Vaginal Rings
1.4.5 Transdermal Patches
4.2 By Type, Global Hormonal Contraceptive Market Size, 2019-2021

5 Impact of Covid-19 on Hormonal Contraceptive Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Household
5.5.3 Clinics
5.2 By Application, Global Hormonal Contraceptive Market Size, 2019-2021
5.2.1 By Application, Global Hormonal Contraceptive Market Size by Application, 2019-2021

6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa

7 Company Profiles
7.1 Ansell Limited
7.1.1 Ansell Limited Business Overview
7.1.2 Ansell Limited Hormonal Contraceptive Quarterly Revenue, 2020
7.1.3 Ansell Limited Hormonal Contraceptive Product Introduction
7.1.4 Ansell Limited Response to COVID-19 and Related Developments
7.2 Bayer AG
7.2.1 Bayer AG Business Overview
7.2.2 Bayer AG Hormonal Contraceptive Quarterly Revenue, 2020
7.2.3 Bayer AG Hormonal Contraceptive Product Introduction
7.2.4 Bayer AG Response to COVID-19 and Related Developments
7.3 Church and Dwight Co
7.3.1 Church and Dwight Co Business Overview
7.3.2 Church and Dwight Co Hormonal Contraceptive Quarterly Revenue, 2020
7.3.3 Church and Dwight Co Hormonal Contraceptive Product Introduction
7.3.4 Church and Dwight Co Response to COVID-19 and Related Developments
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Business Overview
7.4.2 Johnson and Johnson Hormonal Contraceptive Quarterly Revenue, 2020
7.4.3 Johnson and Johnson Hormonal Contraceptive Product Introduction
7.4.4 Johnson and Johnson Response to COVID-19 and Related Developments
7.5 Mayer Laboratories
7.5.1 Mayer Laboratories Business Overview
7.5.2 Mayer Laboratories Hormonal Contraceptive Quarterly Revenue, 2020
7.5.3 Mayer Laboratories Hormonal Contraceptive Product Introduction
7.5.4 Mayer Laboratories Response to COVID-19 and Related Developments
7.6 Merck and Co
7.6.1 Merck and Co Business Overview
7.6.2 Merck and Co Hormonal Contraceptive Quarterly Revenue, 2020
7.6.3 Merck and Co Hormonal Contraceptive Product Introduction
7.6.4 Merck and Co Response to COVID-19 and Related Developments
7.7 Mylan N.V.
7.7.1 Mylan N.V. Business Overview
7.7.2 Mylan N.V. Hormonal Contraceptive Quarterly Revenue, 2020
7.7.3 Mylan N.V. Hormonal Contraceptive Product Introduction
7.7.4 Mylan N.V. Response to COVID-19 and Related Developments
7.8 Pfizer
7.8.1 Pfizer Business Overview
7.8.2 Pfizer Hormonal Contraceptive Quarterly Revenue, 2020
7.8.3 Pfizer Hormonal Contraceptive Product Introduction
7.8.4 Pfizer Response to COVID-19 and Related Developments
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Business Overview
7.9.2 Teva Pharmaceutical Industries Hormonal Contraceptive Quarterly Revenue, 2020
7.9.3 Teva Pharmaceutical Industries Hormonal Contraceptive Product Introduction
7.9.4 Teva Pharmaceutical Industries Response to COVID-19 and Related Developments
7.10 The Female Health Company
7.10.1 The Female Health Company Business Overview
7.10.2 The Female Health Company Hormonal Contraceptive Quarterly Revenue, 2020
7.10.3 The Female Health Company Hormonal Contraceptive Product Introduction
7.10.4 The Female Health Company Response to COVID-19 and Related Developments
7.11 Organon International
7.11.1 Organon International Business Overview
7.11.2 Organon International Hormonal Contraceptive Quarterly Revenue, 2020
7.11.3 Organon International Hormonal Contraceptive Product Introduction
7.11.4 Organon International Response to COVID-19 and Related Developments
7.12 Afaxys
7.12.1 Afaxys Business Overview
7.12.2 Afaxys Hormonal Contraceptive Quarterly Revenue, 2020
7.12.3 Afaxys Hormonal Contraceptive Product Introduction
7.12.4 Afaxys Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix
9.1 About US
9.2 Disclaimer

List of Table

List of Tables
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Hormonal Contraceptive Assessment
Table 9. COVID-19 Impact: Hormonal Contraceptive Market Trends
Table 10. COVID-19 Impact Global Hormonal Contraceptive Market Size
Table 11. Global Hormonal Contraceptive Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Hormonal Contraceptive Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Hormonal Contraceptive Market Growth Drivers
Table 14. Global Hormonal Contraceptive Market Restraints
Table 15. Global Hormonal Contraceptive Market Opportunities
Table 16. Global Hormonal Contraceptive Market Challenges
Table 17. By Players, Hormonal Contraceptive Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Hormonal Contraceptive Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Hormonal Contraceptive Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Hormonal Contraceptive Market
Table 21. Key Players Hormonal Contraceptive Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Hormonal Contraceptive Market Size 2019-2021, (US$ Million)
Table 24. Global Hormonal Contraceptive Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Hormonal Contraceptive Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Hormonal Contraceptive Market Size, 2019-2021 (US$ Million)
Table 57. Ansell Limited Business Overview
Table 58. Ansell Limited Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Ansell Limited Hormonal Contraceptive Product
Table 60. Ansell Limited Response to COVID-19 and Related Developments
Table 61. Bayer AG Business Overview
Table 62. Bayer AG Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Bayer AG Hormonal Contraceptive Product
Table 64. Bayer AG Response to COVID-19 and Related Developments
Table 65. Church and Dwight Co Business Overview
Table 66. Church and Dwight Co Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Church and Dwight Co Hormonal Contraceptive Product
Table 68. Church and Dwight Co Response to COVID-19 and Related Developments
Table 69. Johnson and Johnson Business Overview
Table 70. Johnson and Johnson Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Johnson and Johnson Hormonal Contraceptive Product
Table 72. Johnson and Johnson Response to COVID-19 and Related Developments
Table 73. Mayer Laboratories Business Overview
Table 74. Mayer Laboratories Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Mayer Laboratories Hormonal Contraceptive Product
Table 76. Mayer Laboratories Response to COVID-19 and Related Developments
Table 77. Merck and Co Business Overview
Table 78. Merck and Co Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Merck and Co Hormonal Contraceptive Product
Table 80. Merck and Co Response to COVID-19 and Related Developments
Table 81. Mylan N.V. Business Overview
Table 82. Mylan N.V. Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Mylan N.V. Hormonal Contraceptive Product
Table 84. Mylan N.V. Response to COVID-19 and Related Developments
Table 85. Pfizer Business Overview
Table 86. Pfizer Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Pfizer Hormonal Contraceptive Product
Table 88. Pfizer Response to COVID-19 and Related Developments
Table 89. Teva Pharmaceutical Industries Business Overview
Table 90. Teva Pharmaceutical Industries Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Teva Pharmaceutical Industries Hormonal Contraceptive Product
Table 92. Teva Pharmaceutical Industries Response to COVID-19 and Related Developments
Table 93. The Female Health Company Business Overview
Table 94. The Female Health Company Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. The Female Health Company Hormonal Contraceptive Product
Table 96. The Female Health Company Response to COVID-19 and Related Developments
Table 97. Organon International Business Overview
Table 98. Organon International Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Organon International Hormonal Contraceptive Product
Table 100. Organon International Response to COVID-19 and Related Developments
Table 101. Afaxys Business Overview
Table 102. Afaxys Hormonal Contraceptive Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Afaxys Hormonal Contraceptive Product
Table 104. Afaxys Response to COVID-19 and Related Developments
List of Figures
Figure 1. Hormonal Contraceptive Product Picture
Figure 2. Hormonal Contraceptive Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Hormonal Contraceptive Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Hormonal Contraceptive Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Hormonal Contraceptive Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Hormonal Contraceptive Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Hormonal Contraceptive Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Hormonal Contraceptive Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Hormonal Contraceptive Market Size Market Share, 2019-2021

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3250
$ 4875

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top